You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 7, July 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Comparison of carotid endarterectomy outcomes from randomized controlled trials and Medicare administrative databases

G. J. Stukenborg
Williamson Institute for Health Studies, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.

OBJECTIVE: To compare the characteristics and outcomes demonstrated for participants in randomized controlled trials of carotid endarterectomy with those of the Medicare patient population who received the procedure in 1989. DESIGN: Historical cohort study using Medicare claims data. SETTING: Medicare beneficiary population aged 65 years and older. PATIENTS: Medicare patients 65 years and older who received carotid endarterectomy during 1989. MAIN OUTCOME MEASURES: Perioperative mortality rate and occurrence of transient ischemic attack, stroke, and death within 2 years of surgery. RESULTS: The risk for death within 2 years of the procedure was substantially higher among Medicare patients who received surgery in hospitals with perioperative mortality rates greater than rates demonstrated in the trials (odds ratio, 1.36; 95% confidence interval, 1.29-1.44) and among those with comorbidity that exceeded trial participation criteria (odds ratio, 1.72; 95% confidence interval, 1.64-1.84). CONCLUSIONS: Although carotid endarterectomy trials demonstrate the efficacy of the procedure, this evidence only applies to patients and hospitals with characteristics comparable to those of the trial participants. The importance of this consideration is demonstrated by the substantially higher odds of death experienced among Medicare patients receiving the procedure who had a level of comorbidity that exceeded that of the trial participants or who received their surgery in a hospital with a perioperative mortality rate that exceeded the experience of the hospitals in the trials.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
Yadav et al.
NEJM 2004;351:1493-1501.
ABSTRACT | FULL TEXT  

Surgeon characteristics associated with mortality and morbidity following carotid endarterectomy
O'Neill et al.
Neurology 2000;55:773-781.
ABSTRACT | FULL TEXT  

Carotid Endarterectomy : Where Do We Draw the Line?
Gorelick
Stroke 1999;30:1745-1750.
FULL TEXT  

Methods in health services research: Interpreting the evidence: choosing between randomised and non-randomised studies
McKee et al.
BMJ 1999;319:312-315.
FULL TEXT  

Variation in Carotid Endarterectomy Mortality in the Medicare Population: Trial Hospitals, Volume, and Patient Characteristics
Wennberg et al.
JAMA 1998;279:1278-1281.
ABSTRACT | FULL TEXT  

Indications, Outcomes, and Provider Volumes for Carotid Endarterectomy
Cebul et al.
JAMA 1998;279:1282-1287.
ABSTRACT | FULL TEXT  

Managing carotid stenosis
DTB 1998;36:9-12.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.